IP Library Granted Patent US 8,815,546
Granted Patent B2
US 8,815,546 · App. 13/619,436 · Granted Aug 26, 2014

Methods for multiplexing amplification reactions

Inventors: John Gerdes (Denver, CO); Elaine Best (Ft. Collins, CO); Jeffrey M. Marmaro (Aurora, CO)
Assignee: Applied Biosystems, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,815,546
App. No.
13/619,436
Granted
Aug 26, 2014
Kind
B2
Abstract

A two-step multiplex amplification reaction includes a first step which truncates the standard initial multiplex amplification round to “boost” the sample copy number by only a 100-1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid. In particular, nucleic acid sequences that uniquely identify E. Coli were identified using the multiplex amplification method.

Claims (19)

1. A two-step amplification method, comprising:

a) performing a first amplification step, wherein a nucleic acid sample comprising a target nucleic acid is amplified such that said target nucleic acid is increased by 100-1000 fold, and wherein said first amplification step comprises a multiplex amplification reaction involving at least two primer pairs and results in an amplified nucleic acid sample comprising said target nucleic acid; and

b) performing a second amplification step, wherein said amplified nucleic acid sample from step (a) is amplified, wherein said second amplification step comprises a singleplex amplification reaction.

2. The method of claim 1 , wherein said target nucleic acid is DNA.

3. The method of claim 1 , wherein said target nucleic acid is RNA.

4. The method of claim 1 , wherein said first amplification step is accomplished using a polymerase chain reaction, an isothermal amplification reaction, a nucleic acid sequence-based amplification reaction, a ligase chain reaction, or a strand displacement amplification reaction.

5. The method of claim 1 , wherein said second amplification step is accomplished using a polymerase chain reaction, an isothermal amplification reaction, a nucleic acid sequence-based amplification reaction, a ligase chain reaction, or a strand displacement amplification reaction.

6. The method of claim 1 , wherein said multiplex amplification reaction comprises 5-40 primer pairs.

7. The method of claim 1 , wherein said amplified nucleic acid sample comprising said target nucleic acid is divided into a number of portions at least equal to a number of primer pairs used in step (a) prior to amplification in step (b).

8. The method of claim 1 , wherein said nucleic acid sample is irreversibly bound to a solid phase matrix.

9. The method of claim 1 , wherein said nucleic acid sample is unbound in an aqueous environment.

10. The method of claim 1 , wherein said multiplex and/or singleplex amplification reaction further comprises a polymerase.

11. The method of claim 10 , wherein said polymerase is selected from the group consisting of a DNA polymerase, an RNA polymerase, a transcriptase, or Qβ replicase.

12. The method of claim 1 , wherein said target nucleic acid is a single stranded DNA polynucleotide.

13. The method of claim 1 , wherein said singleplex amplification reaction in step (b) comprises one of said at least two primer pairs used in step (a).

14. The method of claim 1 , wherein said amplified nucleic acid sample from said first amplification step is diluted prior to use in said second amplification step.

15. The method of claim 1 , wherein said first amplification step is performed without consideration of primer design and optimization conditions.

16. The method of claim 1 , wherein said first amplification step results in no detectable amplification due to primer artifacts.

17. The method of claim 1 , wherein said nucleic acid sample is from a limited quantity specimen comprising a very low copy number of said target nucleic acid.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2014
From: GERDES, JOHN C; BEST, ELAINE; MARMARO, JEFFREY M
To: XTRANA, INC.
Reel/Frame 032328/0269 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2014
From: XTRANA, INC.
To: APPLERA CORPORATION
Reel/Frame 032328/0347 →
MERGER Recorded Feb 28, 2014
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 032328/0430 →
MERGER Recorded Feb 28, 2014
From: ATOM ACQUISITION CORPORATION; APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 032328/0455 →
Continuity (5)
Continuation 11944169 · Nov 21, 2007
Division 11176795 · Jul 7, 2005
Division 10441158 · May 19, 2003
Continuation In Part 09589560 · Jun 6, 2000
Related Publication 20130143754A1 · Jun 6, 2013